Common Stock, Shares, Outstanding of GT Biopharma, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
GT Biopharma, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • GT Biopharma, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 25,534,173, a 1043% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

GT Biopharma, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 25,534,173 +23,299,845 +1043% 31 Dec 2025 10-K 02 Mar 2026 2025 FY
Q3 2025 6,051,874 +3,817,546 +171% 30 Sep 2025 10-Q/A 06 Mar 2026 2025 Q3
Q2 2025 3,272,995 +1,038,667 +46% 30 Jun 2025 10-Q/A 06 Mar 2026 2025 Q2
Q1 2025 2,536,397 +1,155,764 +84% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 2,234,328 +853,695 +62% 31 Dec 2024 10-Q/A 06 Mar 2026 2025 Q2
Q3 2024 2,234,328 -39,184,671 -95% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 2,234,328 -38,405,360 -95% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 1,380,633 -35,502,091 -96% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 1,380,633 +289,885 +27% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 41,418,999 +8,911,381 +27% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 40,639,688 +9,946,130 +32% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 36,882,724 +4,537,007 +14% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 1,090,748 -30,971,241 -97% 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 32,507,618 +1,999,358 +6.6% 30 Sep 2022 10-Q 31 Oct 2022 2022 Q3
Q2 2022 30,693,558 +2,549,481 +9.1% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 32,345,717 +11,828,286 +58% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 32,061,989 +26,843,867 +514% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 30,508,260 -47,010,354 -61% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 28,144,077 -47,291,785 -63% 30 Jun 2021 10-Q/A 29 Dec 2021 2021 Q2
Q1 2021 20,517,431 -50,082,002 -71% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 5,218,122 +1,113,140 +27% 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 77,518,614 +10,626,985 +16% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 75,435,862 +22,790,980 +43% 30 Jun 2020 10-Q/A 18 Aug 2020 2020 Q2
Q1 2020 70,599,433 +19,225,016 +37% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 4,104,982 -46,545,496 -92% 31 Dec 2019 10-K 16 Apr 2021 2020 FY
Q3 2019 66,891,629 +16,663,651 +33% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 52,644,882 +2,526,905 +5% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 51,374,417 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 50,650,478 +532,501 +1.1% 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q3 2018 50,227,978 +460,000 +0.92% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 50,117,977 +49,621,536 +9995% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q4 2017 50,117,977 +50,013,759 +47990% 31 Dec 2017 10-K 29 Mar 2019 2018 FY
Q3 2017 49,767,978 +21,549,613 +76% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 496,441 -25,393,499 -98% 30 Jun 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 122,912,868 +101,219,647 +467% 31 Mar 2017 10-Q 28 Apr 2017 2017 Q1
Q4 2016 104,218 -2,295,782 -96% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 28,218,365 -563,496,119 -95% 30 Sep 2016 10-Q/A 28 Feb 2018 2016 Q3
Q2 2016 25,889,940 -565,824,544 -96% 30 Jun 2016 10-Q/A 28 Feb 2018 2016 Q2
Q1 2016 21,693,221 -574,021,263 -96% 31 Mar 2016 10-Q/A 28 Feb 2018 2016 Q1
Q4 2015 2,400,000 +33,412 +1.4% 31 Dec 2015 10-K/A 28 Feb 2018 2016 FY
Q3 2015 591,714,484 0 0% 30 Sep 2015 10-Q 13 Nov 2015 2015 Q3
Q2 2015 591,714,484 +18,662,960 +3.3% 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 595,714,484 +22,662,960 +4% 31 Mar 2015 10-Q 14 May 2015 2015 Q1
Q4 2014 2,366,588 -570,684,936 -100% 31 Dec 2014 10-K/A 28 Feb 2018 2015 FY
Q3 2014 591,714,484 +18,662,960 +3.3% 30 Sep 2014 10-Q 08 Jan 2015 2014 Q3
Q2 2014 573,051,524 0 0% 30 Jun 2014 10-Q 08 Jan 2015 2014 Q2
Q1 2014 573,051,524 0 0% 31 Mar 2014 10-Q 08 Jan 2015 2014 Q1
Q4 2013 573,051,524 +72,477,778 +14% 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q3 2013 573,051,524 +115,844,211 +25% 30 Sep 2013 10-Q 17 Dec 2014 2013 Q3
Q2 2013 573,051,524 +208,751,686 +57% 30 Jun 2013 10-Q 12 Dec 2014 2013 Q2
Q1 2013 573,051,524 +272,751,686 +91% 31 Mar 2013 10-Q 10 Dec 2014 2013 Q1
Q4 2012 500,573,746 +231,273,908 +86% 31 Dec 2012 10-K 08 Jan 2015 2013 FY
Q3 2012 457,207,313 +218,584,697 +92% 30 Sep 2012 10-Q 21 Nov 2012 2012 Q3
Q2 2012 364,299,838 +154,800,323 +74% 30 Jun 2012 10-Q/A 13 Sep 2012 2012 Q2
Q1 2012 300,299,838 31 Mar 2012 10-Q 21 May 2012 2012 Q1
Q4 2011 269,299,838 +119,727,862 +80% 31 Dec 2011 10-K 18 Nov 2014 2012 FY
Q3 2011 238,622,616 30 Sep 2011 10-Q 21 Nov 2011 2011 Q3
Q2 2011 209,499,515 30 Jun 2011 10-Q/A 12 Sep 2011 2011 Q2
Q4 2010 149,571,976 31 Dec 2010 10-K 16 Apr 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.